Table 3 Demographics of seropositive and seronegative (vaccination-naïve) subjects collected in 2021 (study 3)
From: Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections
Seropositive IgG+ | Seronegative IgG− | P-value | |
|---|---|---|---|
Samples | 37 | 40 | |
Sex | |||
Female | 20 (54.1%) | 22 (55.0%) | 1 |
Male | 17 (45.9%) | 18 (45.0%) | |
Age groups | |||
18–29 | 8 (21.6%) | 17 (42.5%) | 0.071 |
30–39 | 8 (21.6%) | 12 (30.0%) | |
40–49 | 12 (32.4%) | 4 (10.0%) | |
50–59 | 7 (18.9%) | 5 (12.5%) | |
60–69 | 2 (5.4%) | 2 (5.0%) | |
Sensing symptoms | |||
None | 13 (35.1%) | 35 (87.5%) | <0.001 |
Loss of smell | 6 (16.2%) | 0 (0%) | |
Loss of taste | 3 (8.1%) | 1 (2.5%) | |
Loss of both | 15 (40.5%) | 4 (10.0%) | |
Missing | 0 (%) | 0 (%) | |
